miraDry Appoints Trish Howell as COO to Boost Operational Excellence

Company - People | May 05, 2025 | 1315 Capital Management LLC

miraDry Appoints Trish Howell as COO to Boost Operational Excellence

miraDry, a leader in non-surgical aesthetic treatments and portfolio company of 1315 Capital Management LLC, announces the strategic appointment of Trish Howell as Chief Operations Officer. With over 20 years in medical technology leadership, Howell will drive miraDry’s operations, supply chain, and regulatory initiatives. Her role aims to enhance operational efficiency, device quality, and customer satisfaction as part of miraDry's global expansion and innovation strategy. Howell's extensive experience includes transforming operational capabilities at major medical device companies and she holds an MBA and a BS in Mechanical Engineering from the University of Michigan. CEO Robert Catlin emphasizes Howell’s potential to contribute to miraDry’s growth and innovation plans.

Sectors

  • Medical Technology
  • Aesthetic Treatment

Geography

  • United States – The main office of miraDry is located in Newport Beach, California, and the article highlights a U.S.-based executive appointment.

Industry

  • Medical Technology – The article involves miraDry, a company specializing in non-surgical medical treatments, highlighting their focus on operational efficiency and innovation in medical technology.
  • Aesthetic Treatment – miraDry operates in the aesthetic treatment sector, providing non-invasive solutions for hyperhidrosis, directly linked to customer satisfaction and quality of life.

Financials

    Participants

    NameRoleTypeDescription
    miraDryTarget CompanyCompanyA leading innovator in non-invasive hyperhidrosis treatment.
    Trish HowellChief Operations OfficerPersonNewly appointed COO at miraDry with extensive experience in medical technology.
    Robert CatlinCEOPersonCEO of miraDry, comments on Trish Howell’s appointment.
    1315 Capital Management LLCPrivate Equity FirmCompanyThe PE firm with an investment interest in miraDry.